G q -coupled GPCRs mediate the oncogenic activity of Gα q -Q209L/P mutants in uveal melanoma cells
Science Signaling · 10.11.2026 · 19 (963)
DOI: 10.1126/scisignal.aeg1191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 10.11.2026. Verfasst von Jenna L Aumiller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, GTP-Binding Protein alpha Subunits, Gq-G11, Mutation. Die Arbeit nennt 105 Literaturangaben. Gefördert von: National Institutes of Health, U.S. Department of Defense, Melanoma Research Institute of Excellence Grant, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University.
Abstract (Originalsprache)
G protein–coupled receptors (GPCRs) stimulate heterotrimeric G proteins (Gαβγ) to facilitate downstream signaling, termination of which relies on a glutamine (Q) residue at position 209 in G protein α subunits. In uveal melanoma (UM), the most common intraocular malignancy in adults, >90% of patients harbor Q209L (QL) or Q209P (QP) mutations in Gα q and Gα 11 proteins. Although mutationally active Gα subunits are thought to signal independently of GPCRs, some constitutively active Gα subunits may retain the ability to bind to GPCRs. Here, we demonstrated that G q -coupled GPCRs, including 5-hydroxytryptamine receptor 2B (HTR2B), enhanced the oncogenic signaling of Gα q -QL. Although HTR2B antagonists alone had little to no inhibitory effects, they enhanced the sensitivity of UM cells to the Gα q -specific inhibitor YM-254890, as measured by signaling, cell viability, and proliferation assays. Last, treatment of UM cells with HTR2B antagonists and low concentrations of YM-254890 shifted endogenous Gα q -QL/QP mutants into an inactive conformation to a greater extent than did YM-254890 alone. Our study demonstrates that G q -coupled GPCRs enhance the oncogenicity of mutationally active Gα q proteins and that antagonism of HTR2B promotes an inactive state of Gα q -QL/QP that increases sensitivity to an inhibitor of Gα q .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
ORCID-Profile: Jenna L Aumiller, Konstantin E Komolov, Philip B Wedegaertner
Förderung
- National Institutes of Health
- U.S. Department of Defense
- Melanoma Research Institute of Excellence Grant, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University
Zitieren
APA
Aumiller, J. L., Luo, J., Komolov, K. E., Sosa, J. M., & Wedegaertner, P. B. (2026). G q -coupled GPCRs mediate the oncogenic activity of Gα q -Q209L/P mutants in uveal melanoma cells. Science Signaling, 19(963). https://doi.org/10.1126/scisignal.aeg1191
Vancouver
Aumiller JL, Luo J, Komolov KE, Sosa JM, Wedegaertner PB. G q -coupled GPCRs mediate the oncogenic activity of Gα q -Q209L/P mutants in uveal melanoma cells. Science Signaling. 2026;19(963). doi:10.1126/scisignal.aeg1191
BibTeX
@article{Aumiller2026,
author = {Aumiller, Jenna L and Luo, Jiansong and Komolov, Konstantin E and Sosa, Julie M and Wedegaertner, Philip B},
title = {G q -coupled GPCRs mediate the oncogenic activity of Gα q -Q209L/P mutants in uveal melanoma cells},
journal = {Science Signaling},
year = {2026},
volume = {19},
number = {963},
doi = {10.1126/scisignal.aeg1191}
}
EUVIMED